Bayer will reorganize its U.S. corporate affairs team in Whippany, separating its communications and public affairs responsibilities.
The U.S. communications function will include current divisional and corporate teams, while the U.S. public affairs function will include current U.S. government relations and policy teams, along with U.S. corporate engagement.
The reorganization aligns with the priorities of the global life sciences company’s domestic crop science, pharmaceutical and consumer health businesses.
Beth Roden has been appointed as senior vice president and head of U.S. communications from her former role as head of global crop science communications. She will also lead communications for consumer health North America. She reports in both roles to Bayer U.S. President Patrick Lockwood-Taylor, who is also president of the North American consumer health business.
Additionally, she will join the U.S. country leadership team and the consumer health North America leadership team, and continue to be a member of the global communications leadership team led by Bayer AG Head of Communications Michael Preuss.
Michael Parrish, vice president of U.S. government relations, will lead U.S. public affairs on an interim basis. He’ll report to Lockwood-Taylor and join the U.S. country leadership team and the global public affairs, science and sustainability team, led by Matthias Berninger.
He’ll continue to lead the corporate and health care government relations and policy teams currently reporting to him.
Roden and Parrish assumed their roles on April 5.
Additionally, the U.S. corporate engagement team led by Al Mitchell, its vice president, will be absorbed into the company’s U.S. public affairs.
Raymond Kerins Jr., senior vice president and head of U.S. corporate affairs, will leave Bayer effective June 14 after eight years to pursue other opportunities.
Lockwood-Taylor said the transformation of U.S. corporate affairs is aimed at supporting the key priorities and accelerated growth plans of Bayer’s businesses in the United States.
“A top business priority for Bayer is to accelerate our transformation as a global life sciences company in pursuit of our vision: Health for All; Hunger for None,” Lockwood-Taylor said in a prepared statement.
“In the U.S. – Bayer’s largest, most important market – supporting the key priorities and accelerated growth plans of our businesses, enhancing our reputation, and building relationships in the new administration on important topics facing the company are essential to our success,” he said. “By making this change now, we are sharpening the focus of each discipline, more closely aligning these business essential activities in the U.S. to our global structure.”